Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...

The Trump administration outlines a plan to cover weight-loss drugs under Medicare and Medicaid, allowing certain state ...

At their peak last year, one share in the company Novo Nordisk cost $142; now, they can be bought for under $50.

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some success ...

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...

Rechelle never thought her body would let her down. She was 35, living in London with a dream job. She was even making plans ...

Novo Nordisk has struggled to adapt to very high demand and a market where celebrities are more influential than doctors.

Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...

TikToker Mikayla Nogueira—who lost 60 pounds after changing her diet and lifestyle—revealed she's considering a boob job since her breasts have turned into "saggy pancakes." ...